EC Number   |
Inhibitors |
Structure |
|---|
    6.3.4.5 | Phenylglyoxal |
ATP and diphosphate protect |
   |
| 6.3.4.5 | Phenylglyoxal |
magnesiumdiphosphate and analogues protect |
|
| 6.3.4.5 | phosphate |
competitive with respect to citrulline and Asp |
|
| 6.3.4.5 | R-lipopolysaccharide (LPS) |
rough-type LPS from Escherichia coli, inhibits argininosuccinate synthetase in a dose-dependent manner, concentration for half inhibition of argininosuccinate synthetase enzyme activity: 0.230 mg/ml |
|
| 6.3.4.5 | recombinant mycoplasma arginine deiminase |
36% decrease in AS activity after rADI treatment |
|
| 6.3.4.5 | S-lipopolysaccharide (LPS) |
smooth-type-LPS from Escherichia coli, inhibits argininosuccinate synthetase in a dose-dependent manner, concentration for half inhibition of argininosuccinate synthetase enzyme activity: 0.024 mg/ml |
|
| 6.3.4.5 | sodium 2-deoxy-2-(3S-(9-phenyl-nonanoyl-oxy) tetradecanoyl) amino-3-O-(9-phenyl-nonanoyl)-D-glucopyranose 4-sulfate |
synthesized lipid A analog, inhibits argininosuccinate synthetase in a dose-dependent manner, concentration for half inhibition of argininosuccinate synthetase enzyme activity: 0.0065 mg/ml |
|
| 6.3.4.5 | threo-3-Hydroxy-3-methylaspartate |
- |
|
| 6.3.4.5 | UTP |
slight |
|
